150 related articles for article (PubMed ID: 7878642)
1. Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonist.
Freed MI; Boike S; Zariffa N; Jorkasky DK
Thromb Haemost; 1994 Oct; 72(4):622-6. PubMed ID: 7878642
[TBL] [Abstract][Full Text] [Related]
2. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
[TBL] [Abstract][Full Text] [Related]
4. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
5. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
6. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
Cook NS; Bruttger O; Pally C; Hagenbach A
Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
[TBL] [Abstract][Full Text] [Related]
7. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
8. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
10. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
[TBL] [Abstract][Full Text] [Related]
12. The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760.
Nichols AJ; Vasko JA; Koster PF; Valocik RE; Rhodes GR; Miller-Stein C; Boppana V; Samanen JM
J Pharmacol Exp Ther; 1994 Aug; 270(2):614-21. PubMed ID: 8071853
[TBL] [Abstract][Full Text] [Related]
13. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
15. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
17. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
[TBL] [Abstract][Full Text] [Related]
18. Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein.
Boncler M; Luzak B; Rozalski M; Golanski J; Rychlik B; Watala C
Thromb Res; 2007; 119(2):209-16. PubMed ID: 16473396
[TBL] [Abstract][Full Text] [Related]
19. Effect of a monoclonal antibody against GPs IIb-IIIa on platelet aggregation and ATP secretion.
Balduini CL; Sinigallia F; Damiani G; Bertolino G; Bisio A; Zocchi E
Exp Hematol; 1986 Jun; 14(5):338-42. PubMed ID: 3011483
[TBL] [Abstract][Full Text] [Related]
20. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Stewart GA; Thompson PJ
Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
